Perhaps the greatest threat to patients with pulmonary embolism (PE) is fai
lure to be diagnosed. Correct decision regarding therapy can be made only a
fter a correct diagnosis. The physician must know: (1) what is the natural
course of events without treatment, (2) how are these events improved by th
erapy, and (3) to which extent are these improvements mitigated by adverse
effects of this therapy.